ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • My Favorites
    • View & print my favorites
  • Search

Home » Meeting Abstracts » ACR/ARHP Annual Meeting 2014

Abstract Number: 2806

Characteristic Phenotype of Peripheral Blood Lymphocytes in Patients with IgG4-Related Disease, Comparing to Primary Sjögren Syndrome and Healthy Controls

Shintaro Hirata, Shingo Nakayamada, Satoshi Kubo, Maiko Yoshikawa, Naoki Yunoue, Kazuhisa Nakano, Kunihiro Yamaoka, Kazuyoshi Saito and Yoshiya Tanaka, The First Department of Internal Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan

Share on X (Twitter) Share on Facebook Share on LinkedIn Share on Email
Print

Meeting: ACR/ARHP Annual Meeting 2014

Keywords: B cells, IgG4 Related Disease, Sjogren's syndrome, T cells and flow cytometry

Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases/Innate Immunity and Rheumatic Disease: Assessing Outcomes of Infections in Rheumatic Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose : IgG4-related disease (IgG4-RD) is a systemic disease that is characterized by the infiltration of IgG4-positive plasma cells and T cells into various organs. However, the characteristic and pathological role of immune cell subsets remains unclear. We have characterized peripheral blood immune cell subsets in patients with IgG4-RD by comparing with patients with primary Sjögren syndrome (pSS) and healthy controls (HC).

Methods : PBMCs were obtained from 8 IgG4-RD and 4 pSS patients as well as from 8 HC. The phenotype of immune cells was analyzed by 8-color staining flow cytometry. T helper cells were categorized as naive, central memory, effector memory and effector T cells by expression of CCR7 and CD45RA. B cells were categorized as naive, IgM memory, switched memory, effector B cell and plasmablast (PB) by expression of IgD, CD27 and CD38. DCs were categorized as myeloid and plasmacytoid DC by expression of CD11c and CD123. The proportion of immune cell subsets was assessed for correlations with serological parameters, including serum IgG, IgG4, and CRP.

Results : Baseline characteristics of patients with IgG4-RD (mean ± SD) were; age 56 ± 20 year, symptom duration 16.3 ± 19.2 months, serum IgG4 628 ± 549 mg/dl, CRP 1.3 ± 2.6 mg/dl, respectively. There was no difference in the proportion of T helper cells (Th1, Th2, Th17, Treg), B cells or DC subsets between IgG4-RD, and pSS, HC,whereas CD3+CD4+CXCR5+CD45RA– Tfh cells were significantly higher in IgG4-RD than HC (p=0.033). In contrast, the proportion of CD3+CD4+CCR7–CD45RA+ effector T cells and CD19+CD27+CD20–CD38+ plasmablasts significantly increased in IgG4-RD compared to pSS and HC (p values: 0.008 and 0.013, respectively). Importantly, the proportion of CD3+CD4+CCR7–CD45RA– effector memory T helper cells was strongly correlated with the ratio of serum IgG4/IgG ratio (rho=0.90, p=0.002), whereas it was not with that of plasmablasts (rho=0.17, p=0.67).

Conclusion : These results revealed that the higher proportion of effector T cells including Tfh cells and the increase of plasmablasts possibly induced by Tfh are characteristically observed in IgG4-RD, but not in pSS. Moreover, serum IgG4/IgG ratio was strongly correlated with ratio of effector memory T cells, but not plasmablasts. Taken together, IgG4 overproduction may be conducted by matured effector phase helper T cells, suggesting a pivotal role of effector phase T cells in pathogenesis of IgG4RD, especially in IgG4 specific production. Further studies are required to elucidate the detailed role of effector phase T cells in the pathogenesis of IgG4-RD.


Disclosure:

S. Hirata,
None;

S. Nakayamada,
None;

S. Kubo,
None;

M. Yoshikawa,
None;

N. Yunoue,
None;

K. Nakano,
None;

K. Yamaoka,
None;

K. Saito,
None;

Y. Tanaka,

BMS, MSD, Chugai, Mitsubishi-Tanabe, Astellas, Abbvie, Daiichi-Sankyo,

2,

UCB Pharma, Mitsubishi-Tanabe, Abbott, Abbvie, Eisai, Chugai, Janssen, Pfizer, Takeda, Astellas, Daiichi-Sankyo, GSK, AstraZeneca, Eli Lilly, Quintiles, MSD, Asahi Kasei,

5,

UCB, Mitsubishi-Tanabe, Abbott, Abbvie, Eisai, Chugai, Janssen, Pfizer, Takeda, Astellas, Daiichi-Sankyo, GSK, AstraZeneca, Eli Lilly, Quintiles, MSD, Asahi Kasei,

8.

ACR Meeting Abstracts - https://acrabstracts.org/abstract/characteristic-phenotype-of-peripheral-blood-lymphocytes-in-patients-with-igg4-related-disease-comparing-to-primary-sjogren-syndrome-and-healthy-controls/

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology